Tideglusib was found to be effective in preventing cell death caused by ethacrynic acid in neuroblastoma cells by inhibiting GSK-3β activity, which resulted in a considerable reduction in TDP-43 phosphorylation. The gene discussed is TARDBP; the disease is neuroblastoma.